Trial NCT04113616

View at ClinicalTrials.gov 
Org. Study IDs: KRT-232-104

Last trial update was posted on 2024-03-22

MeSH Interventions

Cytarabine Decitabine

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myeloproliferative Disorders

Other Conditions

Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN) Relapsed or Refractory Acute Myeloid Leukemia (AML)

Stopping Reasons

In September 2023, the study was terminated because of a Sponsor decision, unrelated to safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID